SYZ Cell Therapy Co.
Records under this name other than patents SYZ Cell Therapy Co. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to SYZ Cell Therapy Co.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,219,675 | Methods of cancer treatment using activated T cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,229,689 | Methods of cancer treatment using activated T cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,967,054 | Methods of cancer treatment using activated T cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,312,597 | Methods of cancer treatment using activated t cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,248,208 | Multiple antigen specific cell therapy methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,219,676 | Methods of cancer treatment using tumor antigen-specific T cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,390,659 | Methods of Obtaining Tumor-Specific T Cell Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 11,471,519 | Methods of cancer treatment using tumor antigen-specific T cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,358,967 | Methods of Obtaining Tumor-Specific T Cell Receptors Formerly held Term ended Term ended Mar 29, 2022 · High confidence | Term ended | Term ended Mar 29, 2022 | High confidence |